Abstract. There are many clinical and experimental reports demonstrating that estrogens and insulin interact when affecting their target organs. Estrogen receptors consist of two isoforms, estrogen receptors-alpha (ER-α) and -beta (ER-β), but their roles in insulin-induced glucose uptake in mature adipose tissue have yet to be clarified. To evaluate the roles of ER-α, expressed predominantly in adipocytes, we have investigated the effects of estradiol (E2), an ER-α selective agonist (PPT), and its selective antagonist (MPP) on glucose uptake and insulin action in 3T3-L1 adipocytes. 3T3-L1 adipocytes were exposed to E2 or PPT and/or MPP at different concentrations. The cells were then subjected to 2-deoxy-D-glucose transport assay, western blot analysis, or RT-PCR analysis. Treatment of these cells with E2 or PPT resulted in biphasic effects on glucose transport, that is high (10 -5 M or 3 × 10 -6 M each) and low (10 -8 M) doses produced inhibition and stimulation, respectively. The favorable effect observed at 10 -8 M of E2 was diminished by treatment with MPP. Western bolt analysis revealed that these effects of E2, PPT and MPP paralleled the level of IRS-1 tyrosine phosphorylation. However, IRS-1 serine phosphorylation, suppressor of cytokine signaling (SOCS)-1,-2,-3 and protein tyrosine phosphatase 1B (PTP1B) expression did not change compaired to control subjects. Our data clearly show that ER-α contributes to insulin stimulated glucose uptake through regulation of the tyrosine phosphorylation of IRS-1 protein.
THERE is a great deal of clinical and experimental evidence demonstrating that sex steroids and insulin interact in exerting their effects on insulin targeting organs [1] . In clinical studies, high concentrations of estrogens, as in pregnancy [2, 3] , trans-sexuality [4] and during menstrual cycles [5] , appear to contribute to the development of insulin resistance. On the other hand, there is considerable evidence against adverse effects of estrogens on glucose metabolism and some for beneficial actions of estrogen. In male mice with complete aromatase deficiency, which are unable to catalyze the formation of estrogens from androgens, progressive insulin resistance is observed [6] . Ovaryectomized (OVX) mice are more insulin-resistant than sham controls and treatment of these OVX mice with estrogen normalizes both glucose tolerance and insulin sensitivity [7] . These results suggest the necessity for appropriate estrogen concentrations to maintain insulin sensitivity, while excessively high concentrations lead to deterioration of insulin sensitivity.
Estrogens mediate their effects through two receptor isoforms, estrogen receptor alpha (ER-α) and estrogen receptor beta (ER-β), each of which is responsible for different biological functions as reflected by their tissue-specific expression patterns. Different roles have been assigned to ER-α and ER-β in mediating the effects of estrogens in adipose tissue. This was suggested by the observations that ER-α gene knockout mice become obese, whereas ER-β knockout mice have a normal amount of adipose tissue [8] [9] [10] . Furthermore, in human adipocytes, the level of ER-β mRNA is much lower than that of ER-α mRNA [11] . These findings indicate that ER-α might play a major role in mediating the effects of estrogens on adipocytes.
In recent years, ER subtype-selective agonists and antagonists contributing to the functional study of these ER subtypes have been developed. Katzenellenbogen et al. [12, 13] have developed compounds that are capable of stimulating ER-α very selectively. Propylpyrazole triol (PPT), a member of the triarylpyrazole class, is more than 10,000-fold more potent on ER-α than on ER-β [12, 13] . Recently, Katzenellenbogen et al. developed a compound known to antagonize ER-α, but not ER-β, by adding basic side-chains typically found in non steroidal anti-estrogens to pyrazole compounds, and this specific antagonist was named methylpiperidino-pyrazole (MPP) [14] . These compounds would presumably be useful for studying the functions of ER-α in adipocytes.
Although evidence that very low and high concentrations of estrogen can cause insulin resistance has been obtained in clinical studies, relatively little information is available on the molecular basis of this mechanism. In vitro, culture of 3T3-L1 adipocytes with high concentrations of estrogens (estrone, estradiol or estriol) resulted in a reduced ability of insulin to stimulate glucose uptake by attenuating insulin signaling events, leading to GLUT4 translocation to the plasma membrane [15] . This study suggests that these estrogens can modulate insulin sensitivity and contribute to the development of insulin resistance by acting directly on adipocytes, but the precise role of ER subtypes was not examined. With the use of an ER-α selective agonist (PPT) and a selective antagonist (MPP), we investigated the role of ER-α in insulin sensitivity in mature 3T3-L1 adipocytes. Furthermore, we examined mechanisms of insulin sensitivity associated with estrogen.
Materials and Methods

Materials and antibodies
We obtained E2 (1,3,5[10] -Estratriene-3,17(-diol), cell culture tested) and PPT (1,3,5-Tris (4-hydroxyphenyl)-4-propyl-1H-pyrazole) from Sigma (St. Louis, MO, USA). MPP (1,3-Bis (4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride) was from Tocris (St. Louis, MO, USA). Anti IRS-1 rabbit polyclonal, anti-Akt1 and anti-GLUT4 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Phospho Akt (serine 473), phospho IRS-1 (serine 307), phospho IRS-1 (serine 612) and phospho Erk antibodies were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-insulin receptor beta subunit (IRβ) antibody was obtained from BD Transduction Laboratories (San Diego, CA, USA). Anti-Erk antibody was purchased from New England Biolabs (Beverly, MA, USA). Anti-GAPDH antibody was from CHEMICON (Temecula, CA, USA). Other reagents are described below.
Cell culture and differentiation
We grew 3T3-L1 fibroblasts in DMEM-HG (Dulbecco's Modified Eagle Medium-high glucose), 10% bovine calf serum at 37°C in 10% CO 2 and split the cultures at about 30% confluence. Cells for use in experiments were grown in the same medium until 2 days after confluence, and then differentiated into adipocytes by treatment with induction medium (0.7 µM insulin, 0.1 µg/ml dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine) [17] . The cells treated with induction medium for 3 days were incubated in DMEM-HG and 10% fetal bovine serum (FBS). The cells were used for experiments at least 8 days after differentiation. After 6 days' induction, our 3T3-L1 fibroblasts are fully differentiated. Because the differentiated cells tend to be dislodged from the culture dishes or plates after 14 days' culture, we completed the experiments before 11 days after the induction. Phenol red-free medium and charcoal-stripped FBS was used while incubating the cells with E2, PPT or MPP to eliminate estrogenic effects of the medium. Phenol red is known to exert weak estrogenic effects [18] .
2-deoxy-D-glucose transport assays
3T3-L1 adipocytes on 24-well plates were pretreated in DMEM-HG, 10% FBS containing E2 or other compounds (PPT or MPP) for 24 h, then deprived of serum by incubation for 3 h in KRH buffer (25 mM HEPES, pH 7.4, 120 mM NaCl, 5 mM KCl, 1.2 mM MgSO 4 , 1.3 mM CaCl 2 and 1.3 mM KH 2 PO 4 ) containing E2, PPT or MPP. E2 and PPT were dissolved in ethanol, MPP in water. The cells were then stimulated with 100 nM insulin for 15 min. Glucose transport assay was initiated by the addition of 2-[ 3 H]deoxy-D-glucose to a final concentration of 100 µM 2-deoxy-D-glucose (20 µCi/mmol). After 5 minutes, the incubation transport assay was terminated with rapid washing in icecold KRH buffer three times. The cells were recovered by adding 0.5 ml/well of 0.1 N NaOH, and radioactivity was measured by liquid scintillation counting.
Immunoprecipitation
3T3-L1 adipocytes grown in 6-well plates were preincubated in DMEM-HG, 10% FBS containing E2 or chemical compounds (PPT or MPP) for 12 h, then deprived of serum by incubation for 12 h in serum-free DMEM-HG containing E2, PPT or MPP. Cells were solubilized with lysis buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1% NP-40, 25 mM NaF, 1 mM sodium orthovanadate, 1 mM benzamidine, 5 µg/ml leupeptin, 5 µg/ml aprotinin, 1 mM DTT and 1 mM phenylmethylsulfonyl fluoride (PMSF)). To examine IRS-1 phosphorylation, 500 µg of total cell lysates were subjected to immunoprecipitation for 1 h at 4°C with polyclonal antibody to IRS-1 (1 µg).
SDS-PAGE and immunoblotting
Total cell lysates and immunoprecipitates were resolved by SDS-PAGE on 8% gels and transferred to PVDF (Amersham, Piscataway, NJ, USA) membrane. Immunolabelled proteins were visualized using HRPconjugated secondary antibodies and the ECL system (Amersham, Piscataway, NJ, USA). Bands were analyzed and quantified using NIH Image version 1.62.
Isolation of RNA and cDNA synthesis 3T3-L1 adipocytes on 6-well plates were incubated in DMEM-HG, 10% FBS for 12 h, then in serum free, DMEM-HG medium containing E2 or PPT for 12 h, and finally washed twice with ice-cold PBS. Cells were homogenized in ISOGEN (NIPPON GENE, Tokyo, Japan), and total RNA was extracted following the manufacturer's protocol.
Total RNA (1 µg) was converted to cDNA utilizing oligo-dT primer and Super Script II (Invitrogen, Carlsbad, CA, USA) in a total reaction volume of 20 µl containing 1 × RT buffer, 0.5 mM dNTP, 0.01 M DTT, and 40 units of ribonuclease inhibitor (RNAsin, Promega, Madison, WI, USA). The reaction mixture was incubated at 65°C for 5 min, 42°C for 50 min and terminated by increasing the temperature to 70°C for 15 min in a thermal cycler as described by the manufacturer.
PCR and Semi quantitative RT-PCR
PCR and semi quantitative RT-PCR were performed in a total reaction volume of 20 µl containing oligonucleotide primers (0.2 µM), 1 × PCR buffer, 1.5 mM MgCl 2 , 0.2 mM dNTP, and 0.5 units of Taq DNA polymerase (Roche, Basel, Switzerland).
Primers for ER-α, -β (16), suppressor of cytokine signaling (SOCS)-1, SOCS-2, SOCS-3, PTP1B and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) were as follows, ER-α: sense 5'-GGCCTGACTCTG CAGCAGCAG-3', anti-sense 5'-GTTGGGGAAGCC CTCTGCTTC-3' (annealing temp. 65°C, 300-bp product), ER-β: sense 5'-GGCATTCTACAGTCCTGCTG-3', antisense 5'-TCTGCATAGAGAAGCGATGA-3' (annealing temp. 60°C 165-bp product), SOCS-1: sense 5'-CAGACACAAGCTGCTACAACC-3', antisense 5'-CGTGACTACCTGAGTTCCTTCC-3' (annealing temp. 58°C, 274-bp product), SOCS-2: sense 5'-CGCGTCTGGCGAAAGCCCTGC-3', antisense 5'-CATTAACAGTCATACTTCCCCAGTACC-3' (annealing temp. 68°C, 69-bp product), SOCS-3: sense 5'-CACAGCAAGTTTCCCGCCGCC-3', antisense 5'-GTGCACCAGCTTGAGTACACAGTC-3' (annealing temp. 68°C, 365-bp product), PTP1B: sense 5'-CTCCTGAACAGGTTAAGGCC-3', antisense CTG GTCAATGTGTGCATGG-3' (annealing temp. 56°C, 269-bp product), GAPDH: sense CAGACACAAGC TGCTACAACC-3', antisense CGTGACTACCTGAG TTCCTTCC-3' (annealing temp. 68°C, 100-bp product). Exactly 4% of the first strand cDNA of each sample was used for PCR amplification by the specific primers indicated above. The reaction mixtures were incubated in a thermal cycler for 40 (ER-α, ER-β), 35 (SOCS-1, SOCS-2, SOCS-3), 26 (PTP1B) and 23 cycles (GAPDH) as follows: at 94°C for 60 sec, at annealing temperatures indicated for 60 sec and at 72°C for 60 sec. In semiquantitative RT-PCR for SOCS-1, SOCS-2, SOCS-3, PTP1B and GAPDH, the cycles were terminated during the phase in which there was exponential generation of PCR products before reaching a plateau. After the cycles had been completed, the tubes were maintained at 72°C for 10 min. Twenty microliters of the PCR product were analyzed on 2% agarose gel in the presence of ethidium bromide. Bands were analyzed and quantified using NIH Image version 1.62.
Statistical analysis
The statistical significance of differences in measured quantities was determined with Student's t-test. A P value less than 0.05 was considered statistically significant. Average values were expressed as means ± standard error of the mean (SEM).
Results
PCR for ER-α and -β in mature 3T3-L1 adipocytes
To determine the functional role of ER-α in mature adipocytes, we studied 3T3-L1 adipocytes that had been cultured for more than 8 days after the induction of differentiation. 3T3-L1 cells subjected to such longterm culture are considered to be representative of mature adipocytes, given that the expression of proteins linked to adipocyte differentiation does not change significantly after 8 days of such treatment [19] . To confirm the expressions of ER-α and -β, mRNA expressions of both ERs on fully differentiated 3T3-L1 adipocytes were examined by the RT-PCR method. ER-α and -β were both expressed in the mature 3T3-L1 adipocytes used in our present experiments (Fig. 1 ).
2-deoxy-D-glucose transport assay during treatment with E2, PPT and MPP
The 3T3-L1 adipocytes we used in the series of experiments were fully differentiated, and no apparent change was observed by the E2 or PPT and/or MPP treatment on inspection.
We first examined the effects of several concentrations of E2 on 2-deoxy-D-glucose transport. 3T3-L1 adipocytes pretreated with E2 for 24 h were compared with cells exposed to the same concentration of vehicle (ethanol: EtOH).
We consistently observed that insulin-stimulated deoxyglucose transport was significantly reduced (29% reduction compared to control samples) by treatment with E2 at 10 -5 M for 24 h (P<0.01) (Fig. 2A) . On the other hand, E2 treatment at 10 -8 M for 24 h significantly increased insulin-stimulated deoxyglucose transport (P<0.05) (Fig. 2A) .
To investigate whether ER-α contributes to the effects observed with E2 treatment, we next examined deoxyglucose transport using PPT, a selective ligand for ER-α. Treatment of cells with PPT at concentrations of 10 -6 and 3 × 10 -6 M decreased insulinstimulated deoxyglucose uptake by 15% and 39%, respectively, as compared to vehicle treated controls (P<0.01) (Fig. 2B) . The increase in deoxyglucose uptake seen with E2 at 10 -8 M was also seen at the PPT concentration of 10 -8 M (P<0.05) (Fig. 2B) .
To confirm that the effects observed with E2 treatment occurred via ER-α, we compared the E2 10 -8 M treated cells with those to which MPP at 10 -6 M had been added. Increased insulin-stimulated deoxyglucose uptake observed with E2 treatment at 10 -8 M was not recognized when the cells were co-incubated with MPP (Fig. 2C) . Incubation of the cells in DMEM containing MPP only had no effect on deoxyglucose transport (data not shown). Unfortunately, we could not test whether the inhibitory effect of a high E2 concentration on insulin stimulated glucose uptake also occurs through ER-α, because this would require a very high concentration of MPP.
Biphasic changes of insulin-stimulated glucose uptake were not associated with the amount of GLUT4 protein expression (Fig. 2D) .
Effects of E2 (10 -5 M) or PPT (3 × 10 -6 M) treatment on protein expression and insulin-stimulated phosphorylation of insulin signaling molecules
We next investigated the effects of a high concentration of E2 or PPT on the molecules involved in insulin signaling for glucose transport. Cells pretreated for 24 h with a high concentration of E2 (10 -5 M) or PPT (3 × 10 -6 M) were incubated in the presence or absence of 100 nM insulin for 3 minutes at 37°C. Incubation in a high concentration of PPT (3 × 10 -6 M) or E2 (10 -5 M) resulted in significant inhibition of insulin-induced tyrosine phosphorylation of IRS-1 (Fig. 3A (b) , Fig. 3B  (b) ) and serine phosphorylation of Akt, a signaling molecule downstream from IRS-1 (Fig. 3A (c), Fig. 3B (c)) (P<0.05). However, high concentrations of E2 and PPT had no effect on the abundance of IRβ (Fig. 3A  (a) , Fig. 3B (a) ), IRS-1 (Fig. 3A (b) , Fig. 3B (b) ), Akt proteins ( Fig. 3A (c) , Fig. 3B (c) ), or the insulinstimulated tyrosine phosphorylation of IRβ (Fig. 3A  (a) , Fig. 3B (a) ). These findings indicate that high concentrations of E2 and PPT produce insulin resistance at the IRS-1 level of the insulin signaling pathway.
To evaluate the IR-Erk pathway, we simultaneously analyzed Erk protein expression and phosphorylation of Erk. However, neither changed and these results indicate E2 and PPT to specifically impair IRS-1 tyrosine phosphorylation ( Fig. 3A (d) , Fig. 3B (d) ).
Effects of E2 (10 -8 M) plus MPP (10 -6 M) treatment on insulin stimulated phosphorylation of insulin signaling molecules
Next, we investigated whether the regulations by (D) 3T3-L1 adipocytes treated with indicated concentrations of E2 for 24 h were analyzed by western blotting. The cells were solubilized and immunoblotted as described in Materials and Methods, and each band was then quantified by NIH image version 1.62. GLUT4 protein was detected using anti-GLUT4 antibody, and the same membrane was then stripped and re-blotted with anti-GAPDH antibody. The amount of GLUT4 protein was normalized by the amount of GAPDH protein, and expressed relative to that of the E2 (-) control. Data are representative of three independent experiments.
tyrosine phosphorylation of IRS-1 observed in E2 and PPT at high concentrations also occur at a relatively low concentration of E2 (10 -8 M). After all, tyrosine phosphorylation of IRβ did not change, while tyrosine phosphorylation of IRS-1 was increased (Fig. 4A, Fig.  4B ). Furthermore, we used an ER-α selective antagonist, MPP, to examine whether the regulation of IRS-1 tyrosine phosphorylation was through ER-α or ER-β activation. With simultaneous addition of MPP and E2, the tyrosine phosphorylation level of IRS-1 returned to the control level (Fig. 4B) .
Fig. 3
Effects of E2 on IRS-1 protein serine phosphorylation and on mRNA expression of SOCS1-3 and PTP1B in mature 3T3-L1 adipocytes Finally, we reviewed serine phosphorylation of IRS-1 protein and expression of the mRNAs of SOCS-1, 2, 3 and PTP1B to examine how E2 regulates IRS-1 tyrosine phosphorylation.
Though IRS-1 has many serine phosphorylation sites, we selected serine 307 and 612 as representative serine phosphorylation sites [20] . A high concentration of E2 (10 -5 M), which decreased IRS-1 tyrosine phosphorylation, did not increase IRS-1 serine phosphorylation (serine 307 and 612) (Fig. 5A) . We also attempted to detect JNK activation using phospho-JNK specific antibody, but found none (data not shown). , and the same membrane was then stripped and re-blotted with an anti-phospho Erk antibody (right panel and graph). B: 3T3-L1 adipocytes treated with a high concentration of PPT were analyzed by western blotting. Experiments in Figure 3B -(a) (b) (c) (d) were the same as those in 3A (a) (b) (c) (d). Data are means ± SEM of at least three independent experiments, and are expressed relative to the value for control cells without insulin. Significant differences in comparison with the control (100 nM insulin without E2 or PPT) are indicated: *P<0.05. pTy, tyrosine phosphorylation. . To analyze tyrosine phosphorylation of IRS-1, total cell lysates were subjected to immunoprecipitation (IP) with antibody to IRS-1. Resulting precipitates were subjected to immunoblot analysis (IB) with antibody to IRS-1. Then, the same membrane was stripped and re-blotted with anti-phosphotyrosine antibody (4G10) (right panel and graph). Data are means ± SEM of three independent experiments, and are expressed relative to the value for control cells without 100 nM insulin. Significant differences in comparison with the control (100 nM insulin without E2) are indicated: *P<0.05.
We next speculated that increased expression of SOCS-1, 2, 3 or PTP1B might be involved in the regulation of IRS-1 tyrosine phosphorylation. We therefore analyzed these mRNA expressions in cells treated for 24 h with or without E2, at concentrations of 10 -9 -10 -5 M, by the semi-quantitative RT-PCR method. There were no changes in the expressions of these mRNAs (Fig. 5B, C) .
Discussion
In our present study on mature 3T3-L1 adipocytes, we demonstrated that exposure to high doses of E2 or PPT (from 3 × 10 -6 M to 10 -5 M) inhibits insulinstimulated glucose transport, and also that cells treated with a relatively low concentration of E2 or PPT (10 -8 M) show increased glucose uptake, without affecting GLUT4 protein expression.
These results are consistent with clinical and experimental observations that estrogen excesses, as in pregnancy [2, 3] , trans-sexuality [4] , and during menstrual cycles [5] , or estrogen deficiencies as in aromatase deficient [6] and OVX animals [7] , cause insulin resistance. Moreover, a selective ER-α antagonist, MPP, diminished the beneficial effect of E2 at 10 -8 M on glucose uptake. This observation suggests that ER-α plays a crucial role in maintaining insulin-stimulated glucose uptake during treatment with a relatively low concentration of E2 in mature adipocytes. Unfortunately, the effect of MPP on cells treated with a high concentration of E2 could not be examined, because such an experiment would require a very high concentration of MPP, a competitive antagonist of ER-α [14] . In our 3T3-L1 adipocytes, treatment with PPT produced biphasic effects on insulin stimulated glucose uptake as was observed with E2 treatment. This result again suggests ER-α to be involved in the modulation of insulin-stimulated glucose uptake by E2. The molecular mechanisms by which estrogen modulates glucose uptake in mature adipocytes have not been well established. Collison et al. previously showed, using fully differentiated 3T3-L1 adipocytes, that the decreased glucose uptake associated with estrogens (estrone, estradiol or estriol) was due at least in part to decreased cellular contents and an altered subcellular distribution of IRS proteins, in turn resulting in a reduction in proximal insulin signaling cascades [15] . However, under our experimental conditions, decreased tyrosine phosphorylation of IRS-1 protein occurred without IRS-1 protein degradation even during treatment with high doses of E2 or PPT. Moreover, according to our data, the increased or decreased insulinstimulated glucose transport in response to E2 or PPT is associated with biphasic changes in tyrosine phosphorylation levels of IRS-1, that is consistent with the very recent report [31] , and these phenomena appear to be mediated mainly through the ER-α isoform.
Herein, we considered the question of how this modulation of insulin signaling was brought about at the level of IRS-1. The involvement of serine phosphorylation of IRS-1 in the desensitization of insulin action has been pointed out [20] [21] [22] . Serine phosphorylation of IRS-1 could induce conformational changes, steric hindrance and cellular re-localization, leading to the decrease in tyrosine phosphorylation by IR. We first examined the possibility that the reduction of IRS-1 tyrosine phosphorylation by estrogen was due to serine phosphorylation of IRS-1. However, IRS-1 serine phosphorylation did not increase. Given that serine phosphorylation (307 or 612) was not increased, it is unlikely that activation of serine kinases for IRS-1 proteins, such as JNK, Erk, mTOR and S6K [20] , were involved, at least on our experimental conditions. However, a very recent report suggested that high concentrations of E2 decrease IRS-1 tyrosine phosphorylation by modulating serine phosphorylation of IRS-1 at serine 307 [31] . The difference in IRS-1 serine phosphorylation results may be explained by the difference in cell clone, or experimental conditions. In addition, we used 3T3-L1 adipocytes 8 to 11 days after differentiation, while they used cells 14 to 16 days after differentiation. As to the decreased IRS-1 tyrosine phosphorylation, other mechanisms such as association of SOCSs with IRS-1 could be involved [23, 24] . Because ERs are transcriptional factors, we speculated that they might modulate the mRNA levels of these target molecules, and regulate IRS-1 tyrosine phosphorylation. In fact, estrogen reportedly up-regulates SOCS-2 and -3 in hepatocytes via ER-α through mechanisms not involving the estrogen response element [25] . However, in adipocytes, E2 treatment did not up-regulate SOCS-1, -2 or -3 mRNA. This discrepancy is probably attributable to estrogen action depending on intracellular machinery that differs among various cell types [26, 27] . PTP1B is an important protein phosphatase that is known to regulate IRS-1 tyrosine phosphorylation [28] [29] [30] . We also examined PTP1B expression, but it did not change after E2 treatments.
In summary, our data suggest that estrogen, through ER-α, modulates insulin-stimulated glucose uptake by regulating tyrosine phosphorylation of IRS-1 protein in mature adipocytes. Further studies are needed to elucidate the mechanisms by which estrogen regulates IRS-1 tyrosine phosphorylation via ER-α, as well as to understand the mechanism of glucose intolerance associated with estrogen excess and deficiencies.
